Efferent blockade of delayed-type hypersensitivity responses in the anterior chamber of the eye.
Syngeneic P91 mastocytomas undergo immunological rejection in the eyes of DBA/2 hosts by a process involving ischemic necrosis. Histopathological features of the ischemic necrotizing pattern of tumor rejection are consistent with a delayed-type hypersensitivity (DTH) effector mechanism. The present study sought to determine if selective depletion of cytotoxic T lymphocyte (CTL) or DTH effector functions by in vivo treatment with either CD8+ or CD4+ monoclonal antibodies would convert the pattern of tumor rejection from an ischemic necrosis DTH-like pattern to a piecemeal necrosis, CTL-like pattern. In vivo treatment with anti-CD4 antibody resulted in the elimination of both CTL and DTH responses, yet the intraocular tumor underwent a characteristic ischemic necrotizing pattern of rejection. By contrast, treatment with anti-CD8 antibody eliminated CTL activity without diminishing DTH responses. Surprisingly, intraocular tumors grew progressively in these hosts even though intense tumor-specific systemic DTH responses were demonstrable. Collectively, the results indicate that classical DTH effector mechanisms mediated by CD4+ T cells are either actively excluded from the intraocular milieu or are suppressed within the eye.